Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | LCK | P06239 | 1/20 | 0.37 |
| ▸ | PPARD | Q03181 | 1/20 | 0.37 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.37 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.37 |
| ▸ | GSR | P00390 | 1/20 | 0.34 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.34 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.34 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.33 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.33 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5855808 | 1.00 | TBXAS1 (0.39) | TBXAS1GPR84FFAR1MAPTLCK | |
| SCHEMBL5856024 | 0.97 | TBXAS1 (0.36) | TBXAS1GPR84FFAR1MAPTLCK | |
| SCHEMBL4128716 | 0.89 | ENPEP (0.37) | TBXAS1GPR84GSRENPEPTSHR | |
| SCHEMBL30018584 | 0.86 | GPR84 (0.46) | TBXAS1GPR84FFAR1MAPTLCK | |
| SCHEMBL9009694 | 0.86 | GPR84 (0.46) | TBXAS1GPR84FFAR1MAPTLCK | |
| SCHEMBL30018402 | 0.86 | GPR84 (0.46) | TBXAS1GPR84FFAR1MAPTLCK | |
| SCHEMBL28261795 | 0.86 | GPR84 (0.46) | TBXAS1GPR84FFAR1MAPTLCK | |
| SCHEMBL3613866 | 0.86 | GPR84 (0.46) | TBXAS1GPR84FFAR1MAPTLCK | |
| SCHEMBL21073899 | 0.86 | GPR84 (0.46) | TBXAS1GPR84FFAR1MAPTLCK | |
| SCHEMBL12851496 | 0.83 | GSR (0.43) | TBXAS1GPR84FFAR1MAPTLCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6916947-B2 | Method of producing amino carboxylic acids | DEGUSSA AG (DE) | 2005-07-12 | — | — | US | disclosed |
| US-20030120084-A1 | Method of producing amino carboxylic acids | DEGUSSA AG | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030120084-A1 | Method of producing amino carboxylic acids | CA1, CA3, CA13 | TBXAS1 4605/4885GPR84 1357/4885FFAR1 436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.